|
C18ORF45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.353530E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.65149999961945E-07 |
| Normal-vs-Stage2 |
1.897360E-01 |
| Normal-vs-Stage3 |
1.065390E-01 |
| Normal-vs-Stage4 |
1.135180E-01 |
| Stage1-vs-Stage2 |
1.435770E-01 |
| Stage1-vs-Stage3 |
2.475700E-03 |
| Stage1-vs-Stage4 |
1.647620E-02 |
| Stage2-vs-Stage3 |
7.492400E-01 |
| Stage2-vs-Stage4 |
8.579800E-01 |
| Stage3-vs-Stage4 |
8.541000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.27660000000119E-05 |
| Normal-vs-AfricanAmerican |
4.340800E-01 |
| Normal-vs-Asian |
5.939700E-02 |
| Caucasian-vs-AfricanAmerican |
7.986400E-02 |
| Caucasian-vs-Asian |
1.556180E-01 |
| AfricanAmerican-vs-Asian |
4.779800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.373300E-04 |
| Normal-vs-Female |
3.846400E-04 |
| Male-vs-Female |
6.374600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.975600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.649440E-04 |
| Normal-vs-Age(61-80Yrs) |
2.240400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.283800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.382800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.069200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.979000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.868200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.296000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.395300E-04 |
| Normal-vs-Grade 2 |
1.04820000002004E-06 |
| Normal-vs-Grade 3 |
2.256600E-03 |
| Normal-vs-Grade 4 |
8.542600E-01 |
| Grade 1-vs-Grade 2 |
4.987200E-01 |
| Grade 1-vs-Grade 3 |
1.708400E-01 |
| Grade 1-vs-Grade 4 |
1.514290E-02 |
| Grade 2-vs-Grade 3 |
5.880000E-02 |
| Grade 2-vs-Grade 4 |
3.432200E-04 |
| Grade 3-vs-Grade 4 |
2.435800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.49079645797678E-11 |
| Normal-vs-ccB subtype |
8.927400E-01 |
| ccA subtype-vs-ccB subtype |
2.12307948999069E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.881900E-03 |
| Normal-vs-N1 |
6.072600E-01 |
| N0-vs-N1 |
5.262800E-01 |
|
|
